Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Early Intervention in STAT3 Dominant-Negative Disease
  2. An, Zixiao Annie; Williams, Kelli W; Urban,Amanda; Ali, Sania; Roy, Susan; Lafeer, Christine; Heimall, Jennifer; Dimitriades, Victoria R; Davis, Joie; Kong, Heidi H; Cowen, Edward W; Holland, Steven M; Freeman, Alexandra F
  3. The Journal of Allergy and Clinical Immunology. In Practice. 2023, Sep 06;
  1. 2.   Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy
  2. Joshi, A.; Garg, H.; Ablan, S.; Freed, E. O.; Nagashima, K.; Manjunath, N.; Shankar, P.
  3. Virology. 2011, Jul; 415(2): 95-106.
  1. 3.   Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag
  2. Rulli, S. J.; Muriaux, D.; Nagashima, K.; Mirro, J.; Oshima, M.; Baumann, J. G.; Rein, A.
  3. Virology. 2006, Apr; 347(2): 364-371.
  1. 4.   Prevention of human papilloma virus (HPV) E7-driven tumorigenesis by dominant negative AP-1 (TAM67) appears to be mediated by Cox-2 repression
  2. Matthews, C. P.; Young, M. R.; Colburn, N. H.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2748S-2749S.
  1. 5.   Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder
  2. Makishima, T.; Rodriguez, C. I.; Robertson, N. G.; Morton, C. C.; Stewart, C. L.; Griffith, A. J.
  3. Human Genetics. 2005, OCT; 118(1): 29-34.
  1. 6.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 7.   IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1
  2. Chau, K. Y.; Keane-Myers, A. M.; Fedele, M.; Ikeda, Y.; Creusot, R. J.; Menozzi, L.; Cousins, D. J.; Manfioletti, G.; Feigenbaum, L.; Fusco, A.; Ono, S. J.
  3. International Immunology. 2005, MAR; 17(3): 297-306.
  1. 8.   Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI
  2. Zakowicz, H.; Yang, H. S.; Stark, C.; Wlodawer, A.; Laronde-Leblanc, N.; Colburn, N. H.
  3. Rna-a Publication of the Rna Society. 2005, MAR; 11(3): 261-274.
  1. 9.   PKC delta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
  2. Jelacic, T.; Linnekin, D.
  3. Blood. 2005, MAR 1; 105(5): 1923-1929.
  1. 10.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 11.   Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes
  2. Nijhara, R.; van Hennik, P. B.; Gignac, M. L.; Kruhlak, M. J.; Hordijk, P. L.; Delon, J.; Shaw, S.
  3. Journal of Immunology. 2004, OCT 15; 173(8): 4985-4993.
  1. 12.   Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1
  2. Ramakrishnan, R.; Fujimura, Y.; Zou, J. P.; Liu, F.; Lee, L.; Rao, V. N.; Reddy, E. S. P.
  3. Oncogene. 2004, SEP 16; 23(42): 7087-7094.
  1. 13.   Contribution of JNK, Mek, Mos and PI-3K signaling to GVBD in Xenopus oocytes
  2. Mood, K.; Bong, Y. S.; Lee, H. S.; Ishimura, A.; Daar, I. O.
  3. Cellular Signalling. 2004, MAY; 16(5): 631-642.
  1. 14.   Late domain-dependent inhibition of equine infectious anemia virus budding
  2. Miranda, S. X.; Ablan, S.; Demirov, D. G.; Chen, C. P.; Montelaro, R. C.; Freed, E. O.
  3. Journal of Virology. 2004 78(2): 724-732.
  1. 15.   The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation
  2. Angeloni, D.; Danilkovitch-Miagkova, A.; Miagkov, A.; Leonard, E. J.; Lerman, M. I.
  3. Journal of Biological Chemistry. 2004 279(5): 3726-3732.
  1. 16.   Inhibition of FGF signaling causes expansion of the endoderm in Xenopus
  2. Cha, S. W.; Hwang, Y. S.; Chae, J. P.; Lee, S. Y.; Lee, H. S.; Daar, I.; Park, M. J.; Kim, J.
  3. Biochemical and Biophysical Research Communications. 2004 315(1): 100-106.
  1. 17.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 18.   Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release
  2. Heidecker, G.; Lloyd, P. A.; Fox, K.; Nagashima, K.; Derse, D.
  3. Journal of Virology. 2004 78(12): 6636-6648.
  1. 19.   Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway
  2. Chie, L.; Amar, S.; Kung, H. F.; Lin, M. C. M.; Chen, H.; Chung, D. L.; Adler, V.; Ronai, Z.; Friedman, F. K.; Robinson, R. C.; Kovac, C.; Brandt-Rauf, P. W.; Yamaizumi, Z.; Michl, J.; Pincus, M. R.
  3. Cancer Chemotherapy and Pharmacology. 2000 45(6): 441-449.
  1. 20.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 21.   Life Without White Fat - a Transgenic Mouse
  2. Moitra, J.; Mason, M. M.; Olive, M.; Krylov, D.; Gavrilova, O.; Marcussamuels, B.; Feigenbaum, L.; Lee, E.; Aoyama, T.; Eckhaus, M.; Reitman, M. L.; Vinson, C.
  3. Genes & Development. 1998 12(20): 3168-3181.
  1. 22.   Expression of Dominant Negative Jun Inhibits Elevated Ap-1 and Nf-Kappa-B Transactivation and Suppresses Anchorage Independent Growth of Hpv Immortalized Human Keratinocytes
  2. Li, J. J.; Rhim, J. S.; Schlegel, R.; Vousden, K. H.; Colburn, N. H.
  3. Oncogene. 1998 16(21): 2711-2721.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel